RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

被引：0

作者：

Catenacci, Daniel V. T. ^{[1
]}

Henderson, Les ^{[1
]}

Cervantes, Gustavo ^{[1
]}

El-Hashani, Essam ^{[1
]}

Karrison, Ted ^{[1
]}

Grushko, Tatyana ^{[1
]}

Olopade, Funmi ^{[1
]}

Tretiakova, Maria ^{[1
]}

Kindler, Hedy L. ^{[1
]}

Salgia, Ravi ^{[1
]}

机构：

[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-LB-124

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-124

引用

页数：2

共 50 条

[1] RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma
Catenacci, Daniel V. T.
Cervantes, Gustavo
Yala, Soheil
Nelson, Erik A.
El-Hashani, Essam
Kanteti, Rajani
El Dinali, Mohamed
Hasina, Rifat
Braegelmann, Johannes
Seiwert, Tanguy
Sanicola, Michele
Henderson, Les
Grushko, Tatyana A.
Olopade, Olufunmilayo
Karrison, Theodore
Bang, Yung-Jue
Kim, Woo Ho
Tretiakova, Maria
Vokes, Everett
Frank, David A.
Kindler, Hedy L.
Huet, Heather
Salgia, Ravi
CANCER BIOLOGY & THERAPY, 2011, 12 (01) : 9 - 46
[2] RON (MST1R) is a Novel Therapeutic Target for Gastroesophageal Adenocarcinoma
Catenacci, D.
Henderson, L.
Tretiakova, M.
Karrison, T.
Salgia, R.
EUROPEAN JOURNAL OF CANCER, 2011, 47 : S474 - S474
[3] THE RON (MST1R)/MSP PATHWAY IS A POTENTIAL THERAPEUTIC TARGET IN MALIGNANT PLURAL MESOTHELIOMA
Baird, Anne-Marie
Byrne, Kenneth O.
Easty, David
Shiels, Liam
Byrne, Annette
Soltermann, Alex
Nonaka, Daisuke
Fennell, Dean
Mutti, Luciano
Pass, Harvey
Opitz, Isabelle
Gray, Steven
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S502 - S502
[4] The RON (MST1R)/MSP pathway is a potential therapeutic target in malignant pleural mesothelioma
Baird, A. -M.
O'Byrne, K. J.
Easty, D.
Shiels, L.
Byrne, A.
Raeppel, S.
Soltermann, A.
Nonaka, D.
Fennell, D. A.
Mutti, L.
Pass, H. I.
Opitz, I.
Gray, S. G.
LUNG CANCER, 2014, 83 : S29 - S30
[5] MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients
Hunt, Brian G.
Wicker, Christina A.
Bourn, Jennifer R.
Lower, Elyse E.
Takiar, Vinita
Waltz, Susan E.
BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (03) : 529 - 540
[6] MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients
Brian G. Hunt
Christina A. Wicker
Jennifer R. Bourn
Elyse E. Lower
Vinita Takiar
Susan E. Waltz
Breast Cancer Research and Treatment, 2020, 181 : 529 - 540
[7] The MST1R/RON Tyrosine Kinase in Cancer: Oncogenic Functions and Therapeutic Strategies
Cazes, Alex
Childers, Betzaira G.
Esparza, Edgar
Lowy, Andrew M.
CANCERS, 2022, 14 (08)
[8] Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy
Joseph Kim
Dong-In Koh
Minki Lee
Yoon Sun Park
Seung-Woo Hong
Jae-Sik Shin
Mi So Lee
Min-Hwa Kim
Jun Hyung Lee
Joonyee Jeong
Seunggeon Bae
Jun Ki Hong
Hong-Rae Jeong
Yea Seong Ryu
Seung-Mi Kim
Mingee Choi
Hyojin Kim
Hyun Ryu
Sun-Chul Hur
Junho Park
Dae Young Hur
Dong-Hoon Jin
Cell Death & Differentiation, 2023, 30 : 2491 - 2507
[9] Targeting isoforms of RON kinase (MST1R) drives antitumor efficacy
Kim, Joseph
Koh, Dong-In
Lee, Minki
Park, Yoon Sun
Hong, Seung-Woo
Shin, Jae-Sik
Lee, Mi So
Kim, Min-Hwa
Lee, Jun Hyung
Jeong, Joonyee
Bae, Seunggeon
Hong, Jun Ki
Jeong, Hong-Rae
Ryu, Yea Seong
Kim, Seung-Mi
Choi, Mingee
Kim, Hyojin
Ryu, Hyun
Hur, Sun-Chul
Park, Junho
Hur, Dae Young
Jin, Dong-Hoon
CELL DEATH AND DIFFERENTIATION, 2023, 30 (12): : 2491 - 2507
[10] THE MACROPHAGE STIMULATING PROTEIN (MSP)-RON/MST1R AXIS IN MALIGNANT PLEURAL MESOTHELIOMA
Gray, Steven G.
Easty, David
Baird, Anne-Marie
Soltermann, Alex
Nonaka, Daisuke
Fennell, Dean A.
Mutti, Luciano
Pass, Harvey I.
Opitz, Isabelle
O'donnell, Dearbhaile
O'Byrne, Kenneth J.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S766 - S767

← 1 2 3 4 5 →